CLASS ACTION UPDATE for TDS, STEM and CRL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 5, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

TDS Shareholders Click Here: https://zlk.com/pslra-1/tds-lawsuit-investigation-submission-form?prid=40311&wire=1
STEM Shareholders Click Here: https://zlk.com/pslra-1/stem-lawsuit-loss-submission-form?prid=40311&wire=1
CRL Shareholders Click Here: https://zlk.com/pslra-1/charles-river-lawsuit-submission-form?prid=40311&wire=1

* ADDITIONAL INFORMATION BELOW *

Telephone and Data Systems, Inc. (NYSE: TDS)

TDS Lawsuit on behalf of: investors who purchased May 6, 2022 - November 3, 2022
Lead Plaintiff Deadline : July 3, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/tds-lawsuit-investigation-submission-form?prid=40311&wire=1

According to the filed complaint, during the class period, Telephone and Data Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) defendants had no reason to believe UScellular's "free upgrade" promotional activity, which was tested and trialed during the second quarter of 2022, was effective at reducing the UScellular's postpaid churn rate as they represented to investors, as opposed to merely adding new postpaid subscribers, when its churn rate was actually increasing or remaining constant over most quarters in the class period; (ii) UScellular was not making progress with respect to its churn rate, as it represented to investors; (iii) UScellular was not in fact balancing its promotional activity and its profitability; (iv) due to extreme competition among postpaid carriers, UScellular did not have the flexibility to offset the costs from widespread, expensive promotions with price increases; and (v) as a result of the Companies' decision for UScellular to continue engaging in heavy promotions to address its postpaid subscriber churn rate despite any lack of positive impact on churn rate, UScellular's profitability substantially declined.

Stem, Inc. f/k/a Star Peak Energy Transition Corp. (NYSE:STEM)

This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired Stem securities: (a) pursuant and/or traceable to certain documents issued in connection with the merger consummated on April 28, 2021, by and among the Company, STPK Merger Sub Corp., and Stem, Inc., a private Delaware corporation; and/or (b) between March 4, 2021, and February 16, 2023, both dates inclusive.
Lead Plaintiff Deadline : July 11, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/stem-lawsuit-loss-submission-form?prid=40311&wire=1

According to the filed complaint, (i) Legacy Stem suffered from material weaknesses in internal control over financial reporting related to accounting for the deferred cost of goods sold and inventory, certain revenue recognition calculations, and internal-use capitalized software calculations; (ii) the Company had overstated Legacy Stem's and its own post-Merger business and financial prospects; (iii) Stem's software revenue did not makeup 100% of the Company's services revenue; (iv) Stem had overstated the benefits expected to flow from its AP partnership; and (v) as a result, the offering documents and defendants public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

Charles River Laboratories International, Inc. (NYSE:CRL)

CRL Lawsuit on behalf of: investors who purchased May 5, 2020 - February 21, 2023
Lead Plaintiff Deadline : July 18, 2023
TO LEARN MORE, VISIT: https://zlk.com/pslra-1/charles-river-lawsuit-submission-form?prid=40311&wire=1

According to the filed complaint, during the class period, Charles River Laboratories International, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE : Levi & Korsinsky, LLP

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.